ABCDEFGHIJKLMNOPQRSTUVWXYZ
1
NameInstitution(s)DepartmentAddressemailORCIDPresent Address (if different from current)Conflict of interest disclosureFunding acknowledgements
2
Matthew C. RobinsonPostEra Inc.Technology2 Embarcadero Center, 8th Floor, San Francisco, CA 94111, United Statesmatthew.robinson@postera.ai
3
Nir LondonThe Weizmann Institute of ScienceChemical and Structural BiologyHertzl 234 st. Rehovot, Israel, 7610001nir.london@weizmann.ac.il0000-0003-2687-0699
N.L. serves on the scientific advisory board of Totus Medicines, Monte Rosa Therapeutics and MetaboMed.
N.L. is the incumbent of the Alan and Laraine Fischer Career Development Chair. N.L. would like to acknowledge funding from the Israel Science Foundation (grant no. 3824/19), the Estate of Emile Mimran, Honey and Dr. Barry Sherman Lab, Dr. Barry Sherman Institute for Medicinal Chemistry and Nelson P. Sirotsky.
4
Efrat ResnickThe Weizmann Institute of ScienceChemical and Structural BiologyHertzl 234 st. Rehovot, Israel, 7610001efrat.resnick@weizmann.ac.il
5
Daniel ZaidmannThe Weizmann Institute of ScienceChemical and Structural BiologyHertzl 234 st. Rehovot, Israel, 7610001daniel.zaidman@weizmann.ac.il
6
Paul GehrtzThe Weizmann Institute of ScienceChemical and Structural BiologyHertzl 234 st. Rehovot, Israel, 7610001paul.gehrtz@weizmann.ac.il
7
Rambabu N. ReddiThe Weizmann Institute of ScienceChemical and Structural BiologyHertzl 234 st. Rehovot, Israel, 7610001rambabu.reddi@weizmann.ac.il
8
Ronen GabizonThe Weizmann Institute of ScienceChemical and Structural BiologyHertzl 234 st. Rehovot, Israel, 7610001ronen.gabizon@weizmann.ac.il
9
Haim BarrThe Weizmann Institute of Science
Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israel National Center for Personalized Medicine
Hertzl 234 st. Rehovot, Israel, 7610001haim.barr@weizmann.ac.il
10
Shirly DubersteinThe Weizmann Institute of Science
Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israel National Center for Personalized Medicine
Hertzl 234 st. Rehovot, Israel, 7610001shirly.valter@weizmann.ac.il
11
Hadeer ZidaneThe Weizmann Institute of Science
Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israel National Center for Personalized Medicine
Hertzl 234 st. Rehovot, Israel, 7610001hadeer.zidane@weizmann.ac.il
12
Khriesto ShurrushThe Weizmann Institute of Science
Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israel National Center for Personalized Medicine
Hertzl 234 st. Rehovot, Israel, 7610001khriesto.shurrush@weizmann.ac.il
13
Galit CohenThe Weizmann Institute of Science
Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israel National Center for Personalized Medicine
Hertzl 234 st. Rehovot, Israel, 7610001galit.cohen@weizmann.ac.il
14
Leonardo J. SolmeskyThe Weizmann Institute of Science
Wohl Institute for Drug Discovery of the Nancy and Stephen Grand Israel National Center for Personalized Medicine
Hertzl 234 st. Rehovot, Israel, 7610001leonardo.solmesky@weizmann.ac.il
15
Alpha LeePostEra Inc.; University of Cambridgealpha.lee@postera.ai
16
Andrew JajackPostEra Inc.Technology2 Embarcadero Center, 8th Floor, San Francisco, CA 94111, United Statesajajack@gmail.com
17
Milan CvitkovicPostEra Inc.Technology2 Embarcadero Center, 8th Floor, San Francisco, CA 94111, United Statesmilan.cvitkovic@postera.ai
18
Jin PanPostEra Inc.Technology2 Embarcadero Center, 8th Floor, San Francisco, CA 94111, United Statesjin.pan@postera.ai
19
Ruby PaiPostEra Inc.Technology2 Embarcadero Center, 8th Floor, San Francisco, CA 94111, United Statesruby.pai@postera.ai
20
Emily Grace RipkaPostEra Inc.Technology2 Embarcadero Center, 8th Floor, San Francisco, CA 94111, United Statesemily.ripka@postera.ai
21
Luong NguyenPostEra Inc.Technology2 Embarcadero Center, 8th Floor, San Francisco, CA 94111, United Statesluong.nguyen@postera.ai
22
Mikhail ShafeevEnamine LtdSynthetic Chemistry78 Chervonotkatska Street, 02094 Kyiv, Ukrainem.shafeev@mail.enamine.net
23
Tatiana MatviiukEnamine LtdSynthetic Chemistry78 Chervonotkatska Street, 02094 Kyiv, Ukrainet.matviyuk@enamine.net
24
Oleg MichurinEnamine LtdSynthetic Chemistry78 Chervonotkatska Street, 02094 Kyiv, Ukraineo.michurin@enamine.net
25
Eugene ChernyshenkoEnamine LtdSynthetic Chemistry78 Chervonotkatska Street, 02094 Kyiv, Ukrainee.chernyshenko@mail.enamine.net
26
Vitaliy A. BilenkoEnamine LtdSynthetic Chemistry78 Chervonotkatska Street, 02094 Kyiv, Ukrainev.bilenko@mail.enamine.net
27
Serhii O. KinakhEnamine LtdSynthetic Chemistry78 Chervonotkatska Street, 02094 Kyiv, Ukraines.kinakh@mail.enamine.net
28
Ivan G. LogvinenkoEnamine LtdSynthetic Chemistry78 Chervonotkatska Street, 02094 Kyiv, Ukrainei.logvinenko@mail.enamine.net
29
Kostiantyn P. MelnykovEnamine LtdSynthetic Chemistry78 Chervonotkatska Street, 02094 Kyiv, Ukrainek.melnykov@mail.enamine.net
30
Victor D. HuliakEnamine LtdSynthetic Chemistry78 Chervonotkatska Street, 02094 Kyiv, Ukrainev.huliak@mail.enamine.net
31
Igor S. TsurupaEnamine LtdSynthetic Chemistry78 Chervonotkatska Street, 02094 Kyiv, Ukrainei.tsurupa@mail.enamine.net
32
Marian GorichkoTaras Shevchenko National University of KyivOrganic ChemistryVolodymyrska str. 64, 01033 Kyiv, Ukraine417lab@gmail.com
33
Aarif ShaikhSai Life SciencesSynthetic Chemistry
Sai Life Sciences Limited, DS-7, ICICI Knowledge Park, Shameerpet, Hyderabad 500 078, Telangana, India, Phone No: +91 40 8418662201
aarif.s@sailife.com
34
Jakir PinjariSai Life SciencesSynthetic Chemistry
Sai Life Sciences Limited, DS-7, ICICI Knowledge Park, Shameerpet, Hyderabad 500 078, Telangana, India, Phone No: +91 40 8418662201
jakir.p@sailife.com
35
Vishwanath SwamySai Life SciencesSynthetic Chemistry
Sai Life Sciences Limited, DS-7, ICICI Knowledge Park, Shameerpet, Hyderabad 500 078, Telangana, India, Phone No: +91 40 8418662201
vishwanath.s@sailife.com
36
Maneesh PingleSai Life SciencesSynthetic Chemistry
Sai Life Sciences Limited, DS-7, ICICI Knowledge Park, Shameerpet, Hyderabad 500 078, Telangana, India, Phone No: +91 40 8418662201
maneesh.p@sailife.com
37
Sarma BVNBSSai Life SciencesSynthetic Chemistry
Sai Life Sciences Limited, DS-7, ICICI Knowledge Park, Shameerpet, Hyderabad 500 078, Telangana, India, Phone No: +91 40 8418662201
sarma.b@sailife.com
38
Anthony AimonDiamond Light Source Ltd; Research Complex at Harwell
Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom
anthony.aimon@diamond.ac.uk0000-0002-9135-129X
39
Frank von Delft
Diamond Light Source Ltd; University of Oxford; Research Complex at Harwell; University of Johannesburg
Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Centre for Medicine Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7DQ, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom;Department of Biochemistry, University of Johannesburg, Auckland Park, 2006, South Africa
frank.von-delft@diamond.ac.uk0000-0003-0378-0017
40
Daren FearonDiamond Light Source Ltd; Research Complex at HarwellLife Sciences
Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom
daren.fearon@diamond.ac.uk0000-0003-3529-7863
41
Louise DunnettDiamond Light Source Ltd; Research Complex at HarwellLife Sciences
Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom
louise.dunnett@diamond.ac.uk0000-0001-6710-6959
42
Alice DouangamathDiamond Light Source Ltd; Research Complex at HarwellLife Sciences
Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom
alice.douangamath@diamond.ac.uk0000-0002-9196-8644
43
Alex DiasDiamond Light Source Ltd; Research Complex at HarwellCEO
Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom
alex.dias@diamond.ac.uk0000-0003-3609-7003
44
Ailsa PowellDiamond Light Source Ltd; Research Complex at HarwellCEO
Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom
ailsa.powell@diamond.ac.uk
0000-0002-0462-2240
45
Jose Brandao NetoDiamond Light Source Ltd; Research Complex at HarwellLife Sciences
Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom
jose.brandao-neto@diamond.ac.uk0000-0001-6015-320X
46
Rachael SkynerDiamond Light Source Ltd; Research Complex at HarwellLife Sciences
Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom
rachael.skyner@diamond.ac.uk0000-0003-3614-6661
47
Warren ThompsonDiamond Light Source Ltd; Research Complex at HarwellLife Sciences
Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom
warren.thompson@diamond.ac.uk0000-0003-1474-7810
48
Tyler Gorrie-StoneDiamond Light Source Ltd; Research Complex at HarwellLife Sciences
Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom
tyler.gorrie-stone@diamond.ac.uk0000-0002-1817-1495
49
Martin WalshDiamond Light Source Ltd; Research Complex at HarwellLife Sciences
Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom
martin.walsh@diamond.ac.uk0000-0001-5683-1151
50
David OwenDiamond Light Source Ltd; Research Complex at HarwellLife Sciences
Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom
david.owen@diamond.ac.uk0000-0001-5774-8202
51
Petra LukacikDiamond Light Source Ltd; Research Complex at HarwellLife Sciences
Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom
petra.lukacik@diamond.ac.uk0000-0002-3179-7273
52
Claire Strain-DamerellDiamond Light Source Ltd; Research Complex at HarwellLife Sciences
Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom
claire.strain-damerell@diamond.ac.uk0000-0003-4964-2090
53
Halina MikolajekDiamond Light Source Ltd; Research Complex at HarwellLife Sciences
Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom
halina.mikolajek@diamond.ac.uk0000-0003-0776-9974
54
Sam HorrellDiamond Light Source Ltd; Research Complex at HarwellLife Sciences
Diamond Light Source, Harwell Science and Innovation Campus, Didcot, OX11 0DE, United Kingdom; Research Complex at Harwell, Harwell Science and Innovation Campus, Didcot OX11 0FA, United Kingdom
sam.horrell@diamond.ac.uk0000-0001-6355-8640
55
Lizbé KoekemoerUniversity of OxfordNuffield Department of MedicineCentre for Medicines Discovery, University of Oxford, ORCRB, Roosevelt Drive, Oxford, Oxon, OX3 7DQ, UKlizbe.koekemoer@cmd.ox.ac.uk0000-0001-9226-9127
56
Tobias KrojerUniversity of OxfordNuffield Department of MedicineCentre for Medicines Discovery, University of Oxford, ORCRB, Roosevelt Drive, Oxford, Oxon, OX3 7DQ, UKtobias.krojer@cmd.ox.ac.uk0000-0003-0661-0814
57
Mike FairheadUniversity of OxfordNuffield Department of MedicineCentre for Medicines Discovery, University of Oxford, ORCRB, Roosevelt Drive, Oxford, Oxon, OX3 7DQ, UKmichael.fairhead@cmd.ox.ac.uk0000-0001-5361-3933
58
Elizabeth M. MacLeanUniversity of OxfordNuffield Department of MedicineCentre for Medicines Discovery, University of Oxford, ORCRB, Roosevelt Drive, Oxford, Oxon, OX3 7DQ, UKbeth.maclean@cmd.ox.ac.uk0000-0003-1680-4292
59
Andrew ThompsonUniversity of OxfordNuffield Department of MedicineCentre for Medicines Discovery, University of Oxford, ORCRB, Roosevelt Drive, Oxford, Oxon, OX3 7DQ, UKandrew.thompson@cmd.ox.ac.uk0000-0002-3910-2317
60
Conor Francis WildUniversity of OxfordNuffield Department of MedicineCentre for Medicines Discovery, University of Oxford, ORCRB, Roosevelt Drive, Oxford, Oxon, OX3 7DQ, UKconor.wild@cmd.ox.ac.uk0000-0003-0654-8141
61
Mihaela D. SmilovaUniversity of OxfordNuffield Department of MedicineCentre for Medicines Discovery, University of Oxford, ORCRB, Roosevelt Drive, Oxford, Oxon, OX3 7DQ, UKmihaela.smilova@cmd.ox.ac.uk0000-0001-6255-7312
62
Nathan WrightUniversity of OxfordNuffield Department of MedicineCentre for Medicines Discovery, University of Oxford, ORCRB, Roosevelt Drive, Oxford, Oxon, OX3 7DQ, UKnathan.wright@cmd.ox.ac.uk
63
Annette von DelftUniversity of OxfordNuffield Department of MedicineCentre for Medicines Discovery, University of Oxford, ORCRB, Roosevelt Drive, Oxford, Oxon, OX3 7DQ, UKannette.vondelft@cmd.ox.ac.uk0000-0002-7699-8140
Funding received from the Oxford Biomedical Research Centre, BRC
64
Carina GileadiUniversity of OxfordNuffield Department of MedicineCentre for Medicines Discovery, University of Oxford, ORCRB, Roosevelt Drive, Oxford, Oxon, OX3 7DQ, UKcarina.gileadi@cmd.ox.ac.uk
Salary support received from the John Fell Fund Oxford
65
Victor L. RangelSchool of Pharmaceutical Sciences of Ribeirao PretoPharmaceutical SciencesAvenida do Café, s/nºRibeirão Preto - SP/CEP 14040-903victor.rangel@usp.br0000-0002-7580-3452
66
Chris SchofieldUniversity of OxfordDepartment of ChemistryChemistry Research Laboratory, 12 Mansfield Rd, Oxford OX1 3TA, United Kingdomchristopher.schofield@chem.ox.ac.uk0000-0002-0290-6565
67
Eidarus SalahUniversity of OxfordDepartment of ChemistryChemistry Research Laboratory, 12 Mansfield Rd, Oxford OX1 3TA, United Kingdomeidarus.salah@chem.ox.ac.uk0000-0001-7552-4966
68
Tika R. MallaUniversity of OxfordDepartment of ChemistryChemistry Research Laboratory, 12 Mansfield Rd, Oxford OX1 3TA, United Kingdomtika.malla@chem.ox.ac.uk0000-0003-4989-6410
69
Anthony TumberUniversity of OxfordDepartment of ChemistryChemistry Research Laboratory, 12 Mansfield Rd, Oxford OX1 3TA, United Kingdomanthony.tumber@chem.ox.ac.uk
70
Tobias JohnUniversity of OxfordDepartment of ChemistryChemistry Research Laboratory, 12 Mansfield Rd, Oxford OX1 3TA, United Kingdomtobias.john@chem.ox.ac.uk
71
Ioannis VakonakisUniversity of OxfordDepartment of BiochemistrySouth Parks Road, Oxford OX1 3QUioannis.vakonakis@bioch.ox.ac.uk0000-0002-4726-0446
Lonza Biologics, Lonza Ltd, Lonzastrasse, CH-3930 Visp, Switzerland.
72
Anastassia L. KantsadiUniversity of OxfordDepartment of BiochemistrySouth Parks Road, Oxford OX1 3QUanastassia.kantsadi@bioch.ox.ac.uk
73
Nicole ZitzmannUniversity of OxfordDepartment of BiochemistryOxford Glycobiology Institute; South Parks Road, Oxford OX1 3QUnicole.zitzmann@bioch.ox.ac.uk0000-0003-1969-4949
Supported by the University of Oxford COVID-19 internal funds, the Oxford Glycobiology Institute Endowment, and grants to Biochemistry Department Oxford, the Dunn School of Pathology.
74
Juliane BrunUniversity of OxfordDepartment of BiochemistryOxford Glycobiology Institute; South Parks Road, Oxford OX1 3QUjuliane.brun@path.ox.ac.uk0000-0002-0964-3681
75
J. L. KiappesUniversity of OxfordDepartment of BiochemistryOxford Glycobiology Institute; South Parks Road, Oxford OX1 3QUjohn.kiappes@bioch.ox.ac.uk0000-0001-6697-6776
76
Michelle HillUniversity of OxfordDepartment of BiochemistryOxford Glycobiology Institute; South Parks Road, Oxford OX1 3QUmichelle.hill@bioch.ox.ac.uk
0000-0002-9289-5811
77
Karolina D WittUniversity of OxfordDepartment of BiochemistryOxford Glycobiology Institute; South Parks Road, Oxford OX1 3QUkarolina.witt@bioch.ox.ac.uk0000-0001-6230-2133
78
Dominic S AlonziUniversity of OxfordDepartment of BiochemistryOxford Glycobiology Institute; South Parks Road, Oxford OX1 3QUdominic.alonzi@bioch.ox.ac.uk0000-0002-1330-9109
79
Laetitia L MakowerUniversity of OxfordDepartment of BiochemistryOxford Glycobiology Institute; South Parks Road, Oxford OX1 3QUlettymakower@gmail.com0000-0003-2385-3973
80
Finny S. VargheseRadboud University Medical CenterDepartment of Medical Microbiology
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein Zuid 28, 6525 GA Nijmegen, The Netherlands
F.Varghese@uniqure.com0000-0002-7900-5482uniQure Biopharma, Amsterdam, the Netherlandsnone
81
Gijs J. OverheulRadboud University Medical CenterDepartment of Medical Microbiology
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein Zuid 28, 6525 GA Nijmegen, The Netherlands
Gijs.Overheul@radboudumc.nl0000-0002-8356-8165none
82
Pascal MiesenRadboud University Medical CenterDepartment of Medical Microbiology
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein Zuid 28, 6525 GA Nijmegen, The Netherlands
pascal.miesen@radboudumc.nl0000-0002-6378-0871none
83
Ronald P. van RijRadboud University Medical CenterDepartment of Medical Microbiology
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein Zuid 28, 6525 GA Nijmegen, The Netherlands
ronald.vanrij@radboudumc.nl0000-0003-0221-4689none
84
Jitske JansenRadboud University Medical CenterDepartment of Pathology
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein Zuid 28, 6525 GA Nijmegen, The Netherlands
Jitske.Jansen@radboudumc.nl
0000-0003-0513-6102
85
Bart SmeetsRadboud University Medical CenterDepartment of Pathology
Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein Zuid 28, 6525 GA Nijmegen, The Netherlands
Bart.Smeets@radboudumc.nl
0000-0002-8466-3367
86
Susana TomásioCollaborative Drug Discovery20 Station Rd, Cambridge, CB1 2JD, UKStomasio@collaborativedrug.com
87
Charlie WeatherallCollaborative Drug Discovery1633 Bayshore Hwy, Burlingame, CA 94010, USAcweatherall@collaborativedrug.com
88
Mariana VaschettoCollaborative Drug Discovery20 Station Rd, Cambridge CB1 2JD, UKmariana@collaborativedrug.com
89
Hannah Bruce MacdonaldMemorial Sloan Kettering Cancer CenterComputational and Systems Biology Program1275 York Ave, New York, NY 10065
hannah.brucemacdonald@choderalab.org
0000-0002-5562-6866
MSD, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT
90
John D. ChoderaMemorial Sloan Kettering Cancer CenterComputational and Systems Biology ProgramMemorial Sloan Kettering Cancer Centerjohn.chodera@choderalab.org0000-0003-0542-119X
JDC is a current member of the Scientific Advisory Board of OpenEye Scientific Software, Redesign Science, and Interline Therapeutics, and has equity interests in Redesign Science and Interline Therapeutics.
The Chodera laboratory receives or has received funding from multiple sources, including the National Institutes of Health, the National Science Foundation, the Parker Institute for Cancer Immunotherapy, Relay Therapeutics, Entasis Therapeutics, Silicon Therapeutics, EMD Serono (Merck KGaA), AstraZeneca, Vir Biotechnology, Bayer, XtalPi, Foresite Laboratories, the Molecular Sciences Software Institute, the Starr Cancer Consortium, the Open Force Field Consortium, Cycle for Survival, a Louis V. Gerstner Young Investigator Award, and the Sloan Kettering Institute.
A complete funding history for the Chodera lab can be found at http://choderalab.org/funding
JDC acknowledges support from NSF NSF RAPID 2033426, NIH grant P30 CA008748, NIH grant R01 GM121505, NIH grant R01 GM132386, and the Sloan Kettering Institute.
91
Dominic RufaMemorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Center1275 York Ave, New York, NY 10065dominic.rufa@choderalab.org0000-0003-0930-9445
92
Matthew WittmannMemorial Sloan Kettering Cancer CenterComputational and Systems Biology Program1275 York Ave, New York, NY 10065matt.wittmann@choderalab.org
93
Melissa L. Boby
Memorial Sloan Kettering Cancer Center;Weil Cornell Medical College
Weil Cornell Graduate School of Medical Sciences1275 York Ave, New York, NY 10065melissa.boby@choderalab.org
0000-0003-1920-206X
94
Michael HenryMemorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer CenterMemorial Sloan Kettering Cancer Centermike.henry@choderalab.org0000-0002-3870-9993
95
William G. GlassMemorial Sloan Kettering Cancer CenterComputational and Systems Biology Program1275 York Ave, New York, NY 10065william.glass@choderalab.org
0000-0002-4099-9280
96
Peter K. Eastman
Department of Bioengineering until Sept. 1, then Department of Chemistry
Stanford University11 Mill Site Road, Scotts Valley, CA 95066peastman@stanford.edu0000-0002-9566-9684
97
Joseph E. CofflandN/ACauldron Development LLC523 6th Street, Petaluma, CA 94952joseph@cauldrondevelopment.com0000-0002-1833-5437
98
David L. DotsonN/ADatryllic LLC280 W. McKinley St., #314, Phoenix AZ, 85003david@datryllic.com0000-0001-5879-2942
99
Ed J. GriffenMedChemica LtdResearch and DevelopmentAlderley Park, Macclesfield, Cheshire. SK10 4TG UK. ed.griffen@medchemica.com0000-0003-0859-554X
100
Willam McCorkindaleUniversity of Cambridge Cavendish Laboratory19 JJ Thomson Avenue, Cambridge, CB3 0HE UK